Skip to main content

Genedata Licenses PathoLead to Novartis Institute for Tropical Diseases

NEW YORK, June 30 (GenomeWeb News) - Genedata today said that the Novartis Institute for Tropical Diseases in  Singapore will use its Phylosopher PathoLead software to study progressive infectious and parasitic disease.


Specifically, the Phylosopher software will serve as an organization-wide scientific management system for proprietary data integration.


Scientists at NITD will use the software to identify and validate target candidates and prioritize the development of drug classes. Research at NITD focuses on Dengue fever and tuberculosis. The ultimate goal would be to develop an anti-viral treatment, the group said.


Almost exactly two years ago, Basel, Switzerland-based Genedata licensed the PathoLead suite of tools to Novartis' Institutes for BioMedical Research.

The Scan

Call to Look Again

More than a dozen researchers penned a letter in Science saying a previous investigation into the origin of SARS-CoV-2 did not give theories equal consideration.

Not Always Trusted

In a new poll, slightly more than half of US adults have a great deal or quite a lot of trust in the Centers for Disease Control and Prevention, the Hill reports.

Identified Decades Later

A genetic genealogy approach has identified "Christy Crystal Creek," the New York Times reports.

Science Papers Report on Splicing Enhancer, Point of Care Test for Sexual Transmitted Disease

In Science this week: a novel RNA structural element that acts as a splicing enhancer, and more.